Atlas Trials

TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve

Clinical trial NCT02147301 · TERMINATED

Trial details

NCT number
NCT02147301
Sponsor
University of California, San Francisco
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatocellular CarcinomaChemoembolization
Start date
2014-12-17
Primary completion
2017-01-27
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.